Clinical trials
Hemorrhage clinical trials
Below are recruiting hemorrhage clinical trials, each written for real people, not researchers. We’re tracking 369 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05891509Recruiting
DTI-guided minimally invasive surgery for deep brain bleeding
This trial studies whether a special scan-guided, minimally invasive procedure can safely remove bleeding in the basal ganglia (deep in the brain) soon after it happens. It may help patients recover better by targeting the bleeding while protecting important brain pathways.
Ganzhou, JiangxiAges 18–80 - NCT05961748Recruiting
Brain and heart illness registry for adults in China
This study is a registry that collects health information from adults who have certain new heart and/or brain conditions. It may help researchers understand how these problems occur together and improve future care planning.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04785976Recruiting
Study of long-term outcomes after a ruptured brain aneurysm bleed
This trial is a long-term follow-up study of people who come to the emergency room with a ruptured brain aneurysm (bleeding in the space around the brain). It helps doctors understand what outcomes are most common and what may affect recovery over time.
Beijing, Beijing MunicipalityAges Any age - NCT05298436Recruiting
South London stroke registry using health data
This study collects information about people who have had a stroke to learn how to improve care and support. It mainly uses existing medical and health records rather than testing a new medicine.
LondonAges 18 years+ - NCT07833410Recruiting
Study of brain bleeding recovery with Chinese hospitals
This study looks at people who have had a brain bleed (intracerebral hemorrhage) to learn more about their recovery over time. It does not involve a new treatment but rather follows participants to understand the condition better.
Changsha, HunanAges 18 years+ - NCT05095857RecruitingPhase 4
Ketamine to improve care in severe acute brain injury
This Phase 4 trial tests whether giving ketamine during anesthesia is safe and helpful for adults with severe sudden brain injuries after surgery. It may improve how patients are sedated and cared for while they are on a breathing machine.
CopenhagenAges 18 years+ - NCT06548737Recruiting
Outcomes after a brain bleed
This study looks at what happens to people after a bleed in the brain. It will help doctors understand how people recover, so they can improve care for future patients.
Hangzhou, ZhejiangAges 18–100 - NCT06548477Recruiting
Albumin for recovery after brain aneurysm bleed
This study tests whether giving the protein albumin can improve recovery after a brain aneurysm has burst. It is for people who have had their aneurysm treated quickly after symptoms started.
DohaAges 18–80 - NCT07781579Recruiting
MRI study to predict bleeding risk in moyamoya disease
This study uses advanced MRI scans to better predict the risk of bleeding in people with moyamoya disease, a rare condition where brain arteries narrow. It aims to improve prevention of bleeding strokes.
Beijing, Beijing MunicipalityAges Any age - NCT07761507Recruiting
Ear stimulation to help wake up after brain bleed surgery
This trial tests a gentle ear stimulation device that may help people regain consciousness after surgery for a brain bleed. It is done while the person is in the hospital and may improve recovery.
BeijingAges 18–75 - NCT05434065RecruitingPhase 2
Celecoxib for brain bleeding after onset
This Phase 2 trial tests whether celecoxib (an anti-inflammatory medicine) can improve outcomes after an intracerebral hemorrhage (a type of stroke caused by bleeding in the brain). It also studies how the medicine may help the body recover. You would need to start treatment quickly after symptoms begin and meet several safety and bleeding-control requirements.
TaipeiAges 20–80 - NCT07743671RecruitingPhase 3
Engasertib for frequent nosebleeds from HHT
This trial tests an experimental pill, engasertib, to reduce frequent nosebleeds in adults with a rare blood vessel condition called hereditary hemorrhagic telangiectasia (HHT). Participation may help if you have moderate to severe nosebleeds and need iron or blood transfusions.
Chicago, IllinoisAges 18 years+ - NCT07728734Enrolling by invitation
Predicting recovery after a brain bleed
This study is testing a way to predict how well people will recover after a brain bleed (intracerebral hemorrhage). It uses information from the first 24 hours to help doctors and families understand the chances of getting better.
Badalona, BarcelonaAges 18 years+ - NCT07701512RecruitingPhase 2
Febuxostat for brain bleed patients managed without surgery
This trial tests if febuxostat, a medicine used for gout, can help people recover from a brain bleed (intracranial hemorrhage) when surgery is not needed. It may reduce inflammation and improve outcomes.
Al Mansurah, Dakahlia GovernorateAges 18 years+ - NCT06670456Recruiting
Brain Bleed Study (Without Surgery)
This study is for people who had a spontaneous brain bleed and did not have surgery. It aims to learn more about their recovery and health over time.
Fuzhou, FujianAges 18 years+ - NCT06673602RecruitingPhase 4
Herbal capsule for memory problems after bleeding stroke
This trial tests a Chinese herbal capsule called Fufang Congrong Yizhi Capsule (FCYC) to see if it can help with memory and thinking problems that start after a bleeding stroke. It is for people who have had robot-assisted surgery for their stroke and also fit a specific pattern in traditional Chinese medicine.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07651631Recruiting
Brain Bleeding Surgery Registry and Treatment Study
This study tracks patients who have had sudden, severe bleeding in the brain and received minimally invasive surgery (a less-invasive surgical approach) to treat it. Researchers want to understand outcomes and improve treatment for this serious condition.
Atlanta, GeorgiaAges 18 years+ - NCT06692504Recruiting
Blood Thinner Side Effects in the Emergency Room
This study looks at side effects of blood thinners (anticoagulants) in patients who visited the emergency department. It helps doctors understand how to better manage these medications.
BesançonAges 18 years+ - NCT07623525RecruitingPhase 1/Phase 2
DIAG723 study for hereditary hemorrhagic telangiectasia
This study tests a new drug called DIAG723 in adults with hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessels and bleeding. Depending on which part of the study you qualify for, the drug may help reduce nosebleeds, improve anemia, or help with lung blood vessel problems caused by HHT.
Camperdown, New South WalesAges 18 years+ - NCT05460793Recruiting
Surgery timing trial for brain bleeding after a stroke
This trial looks at whether starting brain surgery within 8 hours after a type of stroke called intracerebral hemorrhage (bleeding in the brain) can improve outcomes. It’s for adults with a certain amount and location of bleeding and without common causes like an aneurysm or malformation.
AmsterdamAges 18 years+ - NCT06569212RecruitingPhase 4
Beta-blocker to reduce heart damage after brain bleed
This trial tests whether a common beta-blocker (metoprolol) can protect the heart from injury and reduce inflammation after a bleed in the brain (subarachnoid hemorrhage). It may help patients recover better after this type of stroke.
Portland, MaineAges 18 years+ - NCT07614906Recruiting
Nitric Oxide Levels to Predict Blood Vessel Spasms After Brain Bleeding
This study examines whether a substance called nitric oxide in brain fluid can help doctors predict who will develop dangerous blood vessel tightening after a subarachnoid hemorrhage—a serious type of brain bleeding. The goal is to find an early warning sign so doctors can intervene faster.
Boston, MassachusettsAges 18 years+ - NCT07601425RecruitingPhase 1/Phase 2
ATV-1601 Treatment for Hereditary Hemorrhagic Telangiectasia
This trial tests a new drug called ATV-1601 in people with HHT, a genetic condition that causes abnormal bleeding and blood vessel problems. The drug aims to reduce bleeding and anemia caused by HHT.
Phoenix, ArizonaAges 18 years+ - NCT04469517Recruiting
Study of low-oxygen factors in hereditary bleeding disorder
This study looks at how “low-oxygen” signals may affect people with hereditary hemorrhagic telangiectasia (HHT), a genetic bleeding disorder. It may help researchers understand what drives symptoms and could guide future treatments.
Essen, North Rhine-WestphaliaAges 18 years+
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hemorrhage?
- Yes. Clin2 currently lists 369 recruiting hemorrhage studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hemorrhage trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hemorrhage trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.